Therapy Areas: Infectious Diseases
Ichor Biologics is awarded USD 300K by the NIH to develop therapeutic antibodies to treat deadly hantavirus infections.
17 May 2019 - - US-based Ichor Biologics received a USD 300,000 grant from the National Institutes of Health to utilise its platform technology to develop broadly neutralizing antibodies against deadl...
CEL-SCI Presents New Data for Its LEAPS Vaccine in the Treatment of Rheumatoid Arthritis at the American Association of Immunologists 103rd Annual Meeting
17 May 2019 - - US-based CEL-SCI Corp.'s (NYSE American: CVM) senior vice president of research, cellular immunology Daniel Zimmerman, Ph.D. has presented new LEAPS data at the American Asso...
Vedanta Biosciences Closes Extended USD 45.5m Series C Financing
16 May 2019 - - US-based clinical-stage company Vedanta Biosciences has raised an additional USD 18.5m as an extension of its Series C financing, bringing the total for the round to USD 45.5m, the com...
Transgene Receives FDA IND Clearance for Lead MyvacIndividualized Immunotherapy, TG4050, to Commence Clinical Development in Ovarian Cancer
16 May 2019 - - French biotechnology company Transgene (Euronext Paris: TNG) has received Investigational New Drug clearance from the US Food and Drug Administration to proceed with a Phase 1 cli...
Moderna Publishes Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains
16 May 2019 - - Results from two Phase 1 clinical studies have been published showing that mRNA vaccines against H10N8 and H7N9 influenza viruses were well-tolerated and elicited robust immune respons...
Bicycle Therapeutics Adds to Clinical Team to Advance Pipeline
15 May 2019 - - UK-based biopharmaceutical company Bicycle Therapeutics has hired Lisa Mahnke, M.D., Ph.D. as senior vice president and head of clinical and Terrence West, MBA as vice president and he...